NEOGEN CORP Logo

NEOGEN CORP

Develops, manufactures, and markets solutions for food and animal safety.

NEOG | US

Overview

Corporate Details

ISIN(s):
US6404911066
LEI:
Country:
United States of America
Address:
620 LESHER PLACE, 48912 LANSING

Description

Neogen Corporation develops, manufactures, and markets a comprehensive portfolio of solutions dedicated to food and animal safety. The company provides a diverse suite of products and services for the food, beverage, animal, and agriculture industries. Its Food Safety division offers a wide range of diagnostic test kits and systems to detect pathogens, allergens, mycotoxins, and other contaminants. The Animal Safety division provides solutions for livestock and companion animals, including genomics services for genetic analysis, as well as instruments, equipment, cleaners, and disinfectants. Neogen also delivers advanced testing solutions to specialty markets such as healthcare, public health, and laboratory testing, supporting professionals with reliable tools for analysis and research.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-04 22:56 English 11.0 KB
2025-12-02 17:45
PRIMARY DOCUMENT
English 7.1 KB
2025-11-13 14:05 English 13.1 KB
2025-11-07 18:20
PRIMARY DOCUMENT
English 6.6 KB
2025-11-07 18:12
PRIMARY DOCUMENT
English 9.9 KB
2025-11-05 15:20
PRIMARY DOCUMENT
English 7.0 KB
2025-11-04 14:56
PRIMARY DOCUMENT
English 5.9 KB
2025-10-30 13:47
8-K
English 78.8 KB
2025-10-29 15:13
PRIMARY DOCUMENT
English 6.8 KB
2025-10-29 15:08
PRIMARY DOCUMENT
English 6.9 KB
2025-10-29 15:06
PRIMARY DOCUMENT
English 6.8 KB
2025-10-29 15:03
PRIMARY DOCUMENT
English 6.9 KB
2025-10-28 20:51
PRIMARY DOCUMENT
English 6.8 KB
2025-10-28 20:48
PRIMARY DOCUMENT
English 6.8 KB
2025-10-28 20:39
PRIMARY DOCUMENT
English 6.8 KB

Automate Your Workflow. Get a real-time feed of all NEOGEN CORP filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NEOGEN CORP

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NEOGEN CORP via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Arcus Biosciences, Inc. Logo
A clinical-stage biopharmaceutical company developing combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes treatments for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharmaceutical company developing medicines for cardiorenal and gastrointestinal diseases.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharmaceutical company enhancing medicines with its proprietary formulation technology.
United Kingdom
AREC
argenx SE Logo
Develops and commercializes antibody-based therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Develops bacteriophage therapeutics for antibiotic-resistant bacterial infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets in vitro diagnostic (IVD) tests for oncology and bacteriology.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
Clinical-stage biopharma developing oncology drugs for difficult-to-treat diseases.
United States of America
AVBP
ARROWHEAD PHARMACEUTICALS, INC. Logo
Biotechnology company developing RNAi therapies to treat intractable diseases.
United States of America
ARWR
ARS Pharmaceuticals, Inc. Logo
Develops and commercializes needle-free products for administering therapies.
United States of America
SPRY

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.